Phenylepherine containing dosage form
US9492541B2 · kind B2 · utility
1Cited by
19References
112Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2004 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Dec 15, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical dosage form which comprises phenylepherine or a pharmaceutically acceptable salt thereof and a second drug. The dosage form provides a plasma concentration within the therapeutic range of the second drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of phenylepherine. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.